BN Business News
Add your company to Business Communicator →

Business · 29/04/2026

FDA Requests Input on AI-Enabled Optimization of Early-Phase Clinical Trials Pilot Program

The FDA is seeking input on a pilot program to assess the use of AI technologies to improve efficiency and quality in early-phase clinical trials, a critical bottleneck in drug development.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights